Gene · 1946
Papers1,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus. | J Mol Cell Cardiol Plus | 2025 | 41377472 | PubTator, text mining | PubMed |
| Making DAGs even more useful: using augmented causal diagrams to depict counterfactual, study design, measurement, analytical, and interventional features. | Int J Epidemiol | 2025 | 41370626 | PubTator, text mining | PubMed |
| Beyond cell-cell contact: therapeutic potential of Eph signaling in central nervous system tumors. | Front Mol Neurosci | 2025 | 41200151 | PubTator, text mining | PubMed |
| EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | 41006228 | PubTator, text mining | PubMed |
| Independent secondary dose calculation for patient-specific quality assurance: Quantitative benefit of Monte-Carlo and custom beam modeling. | J Appl Clin Med Phys | 2025 | 40988132 | PubTator, text mining | PubMed |
| The impact of authentic leadership on employees' bootleg innovation behavior: the mediating role of affective commitment. | Front Psychol | 2025 | 40978270 | PubTator, text mining | PubMed |
| Structural basis for mTORC1 activation on the lysosomal membrane. | Nature | 2025 | 40963021 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| An efficient and interactive feature selection approach based on copula entropy for high-dimensional genetic data. | Sci Rep | 2025 | 40820100 | PubTator, text mining | PubMed |
| From thought to action: The organization of spinal projecting neurons. | Cell Rep | 2025 | 40818073 | PubTator, text mining | PubMed |
| Femoral vein cutdown as a bailout in failed percutaneous retrieval of migrated coronary sinus reducer: images in cardiology. | Eur Heart J Case Rep | 2025 | 40756681 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Interpretable machine learning-guided single-cell mapping deciphers multi-lineage pancreatic dysregulation in type 2 diabetes. | Cardiovasc Diabetol | 2025 | 40707916 | PubTator, text mining | PubMed |
| In-vitro immunomodulatory efficacy of extracellular vesicles derived from TGF-β1/IFN-γ dual licensed human bone marrow mesenchymal stromal cells. | Stem Cell Res Ther | 2025 | 40629458 | PubTator, text mining | PubMed |
| Advancements in DNA-Driven Precision Modulation of Cell Surface Receptor for Programmable Cellular Functions. | Adv Sci (Weinh) | 2025 | 40588818 | PubTator, text mining | PubMed |
| A high-definition spatiotemporal transcriptomic atlas of mammalian kidney development. | Innovation (Camb) | 2025 | 40470326 | PubTator, text mining | PubMed |
| Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro. | Skelet Muscle | 2025 | 40426233 | PubTator, text mining | PubMed |
| Mef2c Controls Postnatal Callosal Axon Targeting by Regulating Sensitivity to Ephrin Repulsion. | J Neurosci | 2025 | 40228894 | PubTator, text mining | PubMed |
| Role of EFNAs in Shaping the Tumor Immune Microenvironment and Their Impact on Pancreatic Adenocarcinoma Prognosis. | Cancer Manag Res | 2025 | 40190415 | PubTator, text mining | PubMed |
| The potential mechanisms by which Xiaoyao Powder may exert therapeutic effects on thyroid cancer were examined at various levels. | Comput Biol Chem | 2025 | 40056710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1946/papers?page=2